Handling A Wide Range Of Defective Drug Litigation

Pharmaceutical companies are testing new drugs as we speak. Yet, while some companies put their products through extensive testing to ensure that they are safe for consumers, others bypass important testing procedures in their push to get drugs on the market. Still others cover up the dangers they find during testing or afterward.

And when those companies’ drugs cause injury, it is the consumers who pay the price.

We help consumers fight back. At the Girardi | Keese law firm, we have provided a voice for the injured for more than 40 years. Have you been injured by a defective drug? We may already have a team working on litigation involving that drug. Contact us online or by calling 800-401-4530.

Constantly Evolving Defective Drug Practice

Our defective drug practice is constantly evolving. In addition to our Actos, GranuFlo, Mirena and Yaz/Yasmin cases, we currently handle litigation involving:

  • FosamaxFosamax is a drug prescribed for bone diseases, including osteoporosis. Meant to strengthen bones, it has been shown to harden the jawbone, making it brittle and causing teeth to fall out.
  • LevaquinLevaquin is an antibiotic drug used to treat infection but can cause a number of potentially serious side effects.
  • ReglanReglan is used to treat acid reflux disease, heartburn and gastroesophageal reflux disease. It can cause dangerous side effects, from tardive dyskinesia to neuroleptic malignant syndrome (NMS).

New drugs frequently hit the market and we often learn of new injuries from drugs that have been on the market for years. Therefore, if you believe you have a defective drug case, no matter what the drug, do not hesitate to contact us to discuss your options for recovery.


We’ll be in touch within 24 hours. If you have a legal matter you would like to discuss with an attorney from our firm, please call us at
800-401-4530 or complete and submit the email form below, and we will get back to you.

  • This field is for validation purposes and should be left unchanged.